Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (171)

2024

  1. A Survey of the Union of European Neonatal and Perinatal Societies on Neonatal Respiratory Care in Neonatal Intensive Care Units

    Children, Vol. 11, Núm. 2

  2. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study

    The Lancet Neurology, Vol. 23, Núm. 1, pp. 71-80

  3. Clinical predictors and psychosocial risk factors of suicide attempt severity

    Spanish Journal of Psychiatry and Mental Health

  4. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  5. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium

    PLoS ONE, Vol. 18, Núm. 1 January

  3. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    The Lancet Respiratory Medicine, Vol. 11, Núm. 7, pp. 637-649

  4. Cerebral Oximetry Monitoring in Extremely Preterm Infants

    New England Journal of Medicine, Vol. 388, Núm. 16, pp. 1501-1511

  5. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

    European Journal of Neurology, Vol. 30, Núm. 8, pp. 2144-2176

  6. European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI

    Intensive Care Medicine, Vol. 49, Núm. 10, pp. 1212-1222

  7. First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

    Journal for immunotherapy of cancer, Vol. 11, Núm. 2

  8. Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications among Critically Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study∗

    Critical Care Medicine, Vol. 51, Núm. 5, pp. 619-631

  9. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  10. Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study)

    Trials, Vol. 24, Núm. 1

  11. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

  12. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    The Lancet, Vol. 401, Núm. 10373, pp. 269-280

  13. Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations

    American journal of physiology. Cell physiology, Vol. 324, Núm. 3, pp. C769-C776

  14. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

    eClinicalMedicine, Vol. 58

  15. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

    eClinicalMedicine, Vol. 65